drugset / Trial / NCT03830684
A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study in order to evaluate the Baicalein Tablets' safety and efficiency for audit with influenza
Timeline
- Start
- 2019-02-01
- Primary completion
- 2019-05-31
- Completion
- 2019-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baicalein | Small molecule | 400 mg | — |
| Subject | Baicalein | Small molecule | 600 mg | — |